Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.9800
-0.0300 (-2.97%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Marker Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $7.87. The average 1-year stock price forecast is 702.76% higher than the current stock price, while the lowest is $5.60 (+471.43%) and the highest is $10 (+920.41%).
Price Target: $7.87 (+702.76%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Marker Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $8 | Buy | Reiterates | $8 | +716.33% | Oct 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +920.41% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
4.24M
from 3.55M
Increased by 19.61%
Revenue Next Year
20.19M
from 4.24M
Increased by 375.85%
EPS This Year
-0.57
from -0.76
EPS Next Year
-0.53
from -0.57
EPS and Forward PE are based on non-GAAP adjusted numbers.